Jones 1. Paulson DF, Prout GR. a new look al bladder neck obstruction by food administration regulators: Guidelines for the investigation of benign prostatic hyperplasia
Boyarskv S. Jones (1. Paulson DF, Prout GR. A new look al bladder neck obstruction by food administration regulators: guidelines for the investigation of benign prostatic hyperplasia. Trans Am Assoc Genitonrin Surif 1977: 68: 29-32
Iverson P. a point system for selecting operating candidates. in Hinman F r, eds. lienian Prostalic Hypertrophy. New York: Springer
Madsen PO. Iverson P. A point system for selecting operating candidates. In Hinman F r, eds. lienian Prostalic Hypertrophy. New York: Springer. 1983: 763-5
Flyger H. Brasso K er til. Validation of the selfadministered Danish Prostatic Symptom Score (DAN-PSS-I ) system for use in benign prostatic hyperplasia
Hansen BJ. Flyger H. Brasso K er til. Validation of the selfadministered Danish Prostatic Symptom Score (DAN-PSS-I ) system for use in benign prostatic hyperplasia. Kr J Urol 1995: :: 451-8
Rhodes T. Girman CJ et ni. Sexual function of men ages 40-79 years: The Olmsted county study of Urinary Symptoms and Health Status among men
Panser LA. Rhodes T. Girman CJ et ni. Sexual function of men ages 40-79 years: The Olmsted county study of Urinary Symptoms and Health Status among men. J Am Geriatr Soc 1995: 43: 1 107-1 1
;we FC. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: A combined analysis
Löwe FC. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis. Urology 1994: 44: 46-51
Stoner E, Bruskewitz RC et al the effect of ünasleride in men with benign prostatic hyperplasia. the Finasleride Study Group
Gormley GJ. Stoner E, Bruskewitz RC et al The effect of ünasleride in men with benign prostatic hyperplasia. The Finasleride Study Group. N EngJ Med 1992; 327: 1185-91